1. Guo QY*, Wang H*, Duan JH, Luo WW, Zhao RR, Shen YT, Wang BJ, Tao SQ, Sun Y, Ye Q, Bi XM, Yuan H, Wu Q, Lobie PE, Zhu T, Tan S#, Huang X#, Wu ZS#. An alternatively spliced p62 isoform confers resistance to chemotherapy in breast cancer. Cancer Research. 2022;82(21): 4001-4015.
2. Guo K*, Wei YH*, Wang Z, Zhang XL, Zhang X, Liu XX, Wu WY#, Wu ZS#, Zhang LQ#, Cui CP#. Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma. Cell Death Dis. 2022;13(2):97.
3. Shen YT*, Huang X*#, Zhang G*, Jiang B, Li CJ, Wu ZS#. Pan-Cancer Prognostic Role and Targeting Potential of the Estrogen-Progesterone Axis. Frontiers in Oncology 2021;11:636365.
4. Wang XN*, Guo QY*, Wang H*, Yuan XD, Wang BJ, Lobie PE, Zhu T#, Tan S#, Wu ZS#. PCBP2 Posttranional Modifications Induce Breast Cancer Progression via Upregulation of UFD1 and NT5E. Molecular Cancer Research 2021;19(1):86-98.
5. Liu J*, Wu ZS*, Han D, Wei CS, Liang YY, Jiang TC, Chen L, Sha MQ, Cao YJ, Huang F, Geng XP, Yu JS, Shen YJ, Wang H, Feng LJ, Wang D, Fang SY, Wang SY#, Shen YX#. Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-kappaB/Snail Signaling Pathway and Epithelial-Mesenchymal Transition. Hepatology. 2020;71(4):1262-1278.
6. Huang X*#, Wang XN*, Yuan XD, Wu WY, Lobie PE, Wu ZS#. XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation. Oncogene. 2019;38(9):1448-1460.
7. Ding KS*, Tan S*, Huang X, Wang XN, Li XC, Fan R, Zhu Y, Lobie PE, Wang WB#, Wu ZS#. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. J Biol Chem. 2018;293(11):3949-3964.
8. Huang X*, Wu ZS*, Mei YD#, Wu M#. XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling. EMBO J. 2013;32(16):2204-2216.